HIV & AIDS

New therapeutic vaccine approach holds promise for HIV remission

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR), Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical ...

HIV & AIDS

Knowing HIV levels are 'undetectable' may affect sexual behavior

Understanding and responding to behavioral trends in groups that are at high risk for HIV infection is critical to the development of effective strategies that decrease HIV incidence and improve access to care. New research ...

HIV & AIDS

More socioeconomic challenges for hispanic women with HIV

(HealthDay)—Hispanic/Latino women with HIV infection face more socioeconomic and language challenges than men, but the clinical outcomes are similar, according to research published in the Oct. 12 issue of the U.S. Centers ...

Diseases, Conditions, Syndromes

Novel therapeutic approaches to cure chronic HBV infection

Exciting new data presented today at the International Liver Congress 2013 include results from early in vitro and in vivo studies targeting covalently closed circular DNA (cccDNA), which may form the basis of a cure for ...

HIV & AIDS

Sustained viral suppression lower among blacks with HIV

(HealthDay)—A lower percentage of blacks than Hispanics and whites with HIV infection have sustained viral suppression, according to research published in the Feb. 2 issue of the U.S. Centers for Disease Control and Prevention's ...

page 1 from 7